Association between interleukin-8 -251A/T polymorphism and risk of lung cancer: A meta-analysis

Cancer Investigation

Volumn 32, Issue 10, 2014, Pages 518-525

  Gao, Ping ^a   Zhao, Hong ^b   You, Junhao ^b   Jing, Fangfang ^a   Hu, Yi ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Interleukin 8; Lung cancer; Meta analysis; Polymorphism

Indexed keywords

INTERLEUKIN 8; ADENINE; IL8 PROTEIN, HUMAN; THYMINE;

AFRICAN; ARTICLE; ASIAN; CANCER RISK; CASE CONTROL STUDY; ETHNICITY; EUROPEAN; GENETIC ASSOCIATION; GENETIC MODEL; GENOTYPE; HUMAN; LUNG CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; ASIAN CONTINENTAL ANCESTRY GROUP; BIBLIOGRAPHIC DATABASE; BIOLOGY; ETHNOLOGY; GENETIC PREDISPOSITION; GENETICS; LUNG NEOPLASMS; META ANALYSIS; METABOLISM; PROCEDURES;

ADENINE; ASIAN CONTINENTAL ANCESTRY GROUP; COMPUTATIONAL BIOLOGY; DATABASES, BIBLIOGRAPHIC; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTERLEUKIN-8; LUNG NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; THYMINE;

EID: 84911892431     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2014.964410     Document Type: Article

References (39)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69-90.
2. Sugimura H, Yang P. Long-term survivorship in lung cancer: a review. Chest 2006;129:1088-1097.
3. Hecht SS. Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention. Lancet Oncol 2002;3:461-469.
4. Adlkofer F. Lung cancer due to passive smoking - a review. Int Arch Occup Environ Health 2001;74:231-241.
5. Oltulu YM, Coskunpinar E, Ozkan G, Aynaci E, Yildiz P, Isbir T, et al. Investigation of NF-κB1 and NF-κBIA gene polymorphism in non-small cell lung cancer. Biomed Res Int 2014;2014:530381.
6. Yu X, Rao J, Lin J, Zhang Z, Cao L, Zhang X. Tag SNPs in complement receptor-1 contribute to the susceptibility to non-small cell lung cancer. Mol Cancer 2014;13:56.
7. Wang L, Chen Z, Wang Y, Chang D, Su L, Guo Y, et al. The association of c.1471G>A genetic polymorphism in XRCC1 gene with lung cancer susceptibility in Chinese Han population. Tumour Biol 2014;35:5389-5393.
8. Yan F, Xu JF, Liu XF, Li XH. Interaction between smoking and CYP2C19∗3 polymorphism increased risk of lung cancer in a Chinese population. Tumour Biol 2014;35:5295-5298.
9. Fitzpatrick FA. Inflammation, carcinogenesis and cancer. Int Immunopharmacol 2001;1:1651-1667.
10. O'Byrne KJ, Dalgleish AG.. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 2001;85:473-483.
11. Cohen BH, Diamond EL, Graves CG, Kreiss P, Levy DA, Menkes HA, et al. A common familial component in lung cancer and chronic obstructive pulmonary disease. Lancet 1977;2(8037):523-526.
12. Santillan AA, Camargo CA Jr, Colditz GA. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control 2003;14:327-334.
13. Gales D, Clark C, Manne U, Samuel T. The Chemokine CXCL8 in Carcinogenesis and Drug Response. ISRN Oncol 2013;2013:859154.
14. Sparmann A, Bar-Sagi D. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 2004;6:447-458.
15. Balkwill F. The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 2004;14:171-179.
16. Zlotnik A. Chemokines in neoplastic progression. Semin Cancer Biol 2004;14:181-185.
17. Hull J, Thomson A, Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 2000;55:1023-1027.
18. Campa D, Zienolddiny S, Maggini V, Skaug V, Haugen A, Canzian F. Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis 2004;25:229-235.
19. Campa D, Hung RJ, Mates D, Zaridze D, Szeszenia-Dabrowska N, Rudnai P, et al. Lack of association between -251 T>A polymorphism of IL8 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2005;14:2457-2458.
20. Lee KM, Shen M, Chapman RS, Yeager M, Welch R, He X, et al. Polymorphisms in immunoregulatory genes, smoky coal exposure and lung cancer risk in Xuan Wei, China. Carcinogenesis 2007;28:1437-1441.
21. Vogel U, Christensen J, Wallin H, Friis S, Nexø BA, Raaschou-Nielsen O, et al. Polymorphisms in genes involved in the inflammatory response and interaction with NSAID use or smoking in relation to lung cancer risk in a prospective study. Mutat Res 2008;639:89-100.
22. Rafrafi A, Chahed B, Kaabachi S, Kaabachi W, Maalmi H, Hamzaoui K, et al. Association of IL-8 gene polymorphisms with non small cell lung cancer in Tunisia: a case control study. Hum Immunol 2013;74:1368-1374.
23. Bhat IA, Pandith AA, Bhat BA, Naykoo NA, Qasim I, Rasool R, et al. Lack of association of a common polymorphism in the 3′ - UTR of interleukin 8 with non small cell lung cancer in Kashmir. Asian Pac J Cancer Prev 2013;14:4403-4408.
24. Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med 1997;127:820-826.
25. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-748.
26. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-188.
27. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
28. Cheng D, Hao Y, Zhou W, Ma Y. Positive association between Interleukin-8 -251A > T polymorphism and susceptibility to gastric carcinogenesis: a meta-analysis. Cancer Cell Int 2013;13(1):100.
29. Wang Z, Wang C, Zhao Z, Liu F, Guan X, Lin X, et al. Association between -251A>T polymorphism in the interleukin-8 gene and oral cancer risk: a meta-analysis. Gene 2013;522:168-176.
30. Gao LB, Pan XM, Jia J, Liang WB, Rao L, Xue H, et al. IL-8 -251A/T polymorphism is associated with decreased cancer risk among population-based studies: evidence from a meta-analysis. Eur J Cancer 2010;46:1333-1343.
31. Hung RJ, McKay JD, Gaborieau V, Boffetta P, Hashibe M, Zaridze D, et al. A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 2008;452:633-637.
32. Amos CI, Wu X, Broderick P, Gorlov IP, Gu J, Eisen T, et al. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 2008;40:616-622.
33. Thorgeirsson TE, Geller F, Sulem P, Rafnar T, Wiste A, Magnusson KP, et al. A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 2008;452:638-642.
34. Wang Y, Broderick P, Webb E, Wu X, Vijayakrishnan J, Matakidou A, et al. Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nat Genet 2008;40:1407-1409.
35. McKay JD, Hung RJ, Gaborieau V, Boffetta P, Chabrier A, Byrnes G, et al. Lung cancer susceptibility locus at 5p15.33. Nat Genet 2008;40:1404-1406.
36. Hu Z, Wu C, Shi Y, Guo H, Zhao X, Yin Z, et al. A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet 2011;43:792-796.
37. Shiraishi K, Kunitoh H, Daigo Y, Takahashi A, Goto K, Sakamoto H, et al. A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population. Nat Genet 2012;44:900-903.
38. Zhang R, Zhao Y, Chu M, Wu C, Jin G, Dai J, et al. Pathway analysis for genome-wide association study of lung cancer in Han Chinese population. PLoS One 2013;8:e57763.
39. Wang N, Zhou R, Wang C, Guo X, Chen Z, Yang S, Li Y. -251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case-control studies. Mol Biol Rep 2012;39:2831-2841.